BlackRock Group LTD - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2016$448,000
+0.9%
83,725
+6.2%
0.00%
Q3 2016$444,000
+5.2%
78,809
+2.7%
0.00%
Q2 2016$422,000
-23.8%
76,702
+2.7%
0.00%
Q1 2016$554,000
+32.5%
74,664
+48.6%
0.00%
Q4 2015$418,000
+84.1%
50,257
+99.8%
0.00%
Q3 2015$227,000
+6.1%
25,153
+40.9%
0.00%
Q2 2015$214,000
+67.2%
17,846
+49.8%
0.00%
Q1 2015$128,000
+966.7%
11,915
+160.5%
0.00%
Q3 2014$12,0004,5740.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders